Performance liquid chromatographic analysis of glipizide: Application to in vitro and in vivo studies

Journal of Chromatographic Science

Volumn 41, Issue 6, 2003, Pages 295-300

  Dhawan, S ^a   Singla, A K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; GLIBENCLAMIDE; GLIPIZIDE;

ACCURACY; ACIDITY; ARTICLE; CONTROLLED DRUG RELEASE; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 0038602731     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/41.6.295     Document Type: Article

References (30)

1. R.N. Brogden, R.C. Heel, G.E. Pakes, T.M. Speight, and G.S. Avery, Glipizide: a review of its pharmacological properties and therapeutic use. Drugs 18: 329-53 (1979).
2. C.M. Peterson, R.V. Sims, R.L. Jones, and F. Rieders. Bioavailability of glipizide and its effect on blood glucose and insulin levels in patients with non-insulin-dependent diabetes. Diabetes Care 5: 497-500 (1982).
3. M. Berelowitz, C. Fischette, W. Cefalu, D.S. Schade, T. Sutfin, and I.A. Kourides. Comparative efficacy of once daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM. Diabetes Care 17:1460-64 (1994).
4. L. Blonde, R.D. Guthrie, L. Tive, and C. Fischette. The Glipizide GITS efficacy and safety trial study group. Glipizide GITS is effective and safe in a wide range of NIDDM patients: results of a double blind, placebo controlled efficacy and safety trial. Diabetes 45(suppl 2): 285A (1996).
5. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:977-86 (1983).
6. United States Pharmacopeia. XXIII National Formulary 18. United States Pharmacopeial Convention, Inc., Rockville, MD, suppl. 1, 1995, p. 2465.
7. FIP Guidelines. Dissolution testing of solid oral dosage products: joint report of the Section for Official Laboratories and Medicines Control Services and the Section of Industrial Pharmacists of the FIP. Drug Inf. J. 30:1071-84 (1997).
8. H.J. Huck. Chromatography. Biomed. Appl. 3:533-37 (1978).
9. P. Hartvig, C. Fagerland, and H. Gyllen. Electron-capture gas chromatography of plasma sulphonylureas after extractive methylation. J. Chromatogr. 180:17-24 (1980).
10. F. Magni, L. Marazzini, S. Pereira, L. Monti, and M. Galli Kienle. Identification of sulfonylureas in serum by electrospray mass spectrometry. Anal. Biochem. 282:136-41 (2000).
11. M. Nunez, J.E. Ferguson, D. Machacek, G. Jacob, R.P. Oda, G.M. Lawson, and J.P. Landers. Detection of hypoglycemic drugs in human urine using micellar electrokinetic chromatography. Anal. Chem. 67: 3668-75 (1995).
12. G.M. Shenfield, J.S. Boutagy, and C. Webb. A screening test for detecting sulfonylureas in plasma. Ther. Drug Monit. 67: 3668-75 (1995).
13. M. Vasudevan, J. Ravi, S. Ravisankar, and B. Suresh. Ion-pair liquid chromatography technique for the estimation of metformin in its multicomponent dosage forms. J. Pharm. Biomed. Anal. 25: 77-84 (2001).
14. H. Emilsson. High-performance liquid chromatographic determination of glipizide in human plasma and urine. J. Chromatogr. 421: 319-26 (1987).
15. E. Wahlin-Boll and A. Melander. A high performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. J. Chromatogr. 164: 541-46 (1979).
16. A. Sener, A.G. Akkan, and W.J. Malaisse. Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma. Acta Diabetol. 32: 64-68 (1995).
17. B.J. Starkey, G.P. Mould, and J.D. Teale. The determination of sulphonyl urea drugs by HPLC and its clinical application. J. Liq. Chromatogr. 12:233-42 (1994).
18. D.W. Hill and A.J. Kind. Reversed-phase solvent gradient HPLC retention indexes of drugs. J. Anal. Toxicol. 18: 233-42 (1994).
19. R.B. Miller, D. Dadgar, and M. Lanade. High-performance liquid chromatographic method for the determination of indapamide in human whole blood. J. Chromatogr. 614: 293-98 (1993).
20. Shimadzu Corporation. SPD IOA/AV Instruction Manual. Analytical Insruments Division, Kyoto, Japan, 1991, pp. 15.17-15.19.
21. "Glipizide, in vivo bioequivalence and in vitro dissolution testing." In Guidance for Industry. Office of Generic Drugs, Rockville, MD.
22. M. Grover, M. Gulati, and S. Singh. Stability-indicationg analysis of isoxazolyl penicillins using dual wavelength high-performance chromatography. J. Chromatogr. B 708:153-59 (1998).
23. R. Yost, J. Stoveken, and W. MacLean. Positive peak identification in liquid chromatography using absorbance ratioing with a variable-wavelength spectrophotometric detector. J. Chromatogr. 134: 73-82 (1977).
24. A. Grant and P.K. Bhattacharya. Application of derivative spectroscopy to the determination of chromatographic peak purity, J. Chromatogr. 347: 219-35 (1985).
25. F.C. Sanchez, M.S. Khots, D.L. massart, and J.O. DeBeer. Algorithm for the assessment of peak purity in liquid chromatography with photodiode array detection. Anal. Chim. Acta 285: 181-92 (1994).
26. C.M. Riley. Statistical parameters. In Progress in Pharmaceutical and Biomedical Analysis, C.M. Riley and T.W. Rosanke, Eds. Elsevier, Oxford, U.K., 1996, pp. 54, 232.
27. A.F. Fell, B.J. Clark, and H.P. Scott. Computer-aided strategies for archieve retrieval and sensitivity enhancement in the identification of drugs by photo diode array detection in high-performance liquid chromatography. J. Chromatogr. 316: 423-40 (1984).
28. A.F. Fell, B.J. Clark, and H.P. Scott. Analysis and Characterizaion of aromatic amino acids, metabolites and peptides by rapid-scanning photo diode array detection in high-performance liquid chromatography, J. Chromatogr. 297: 203-14 (1984).
29. S. Dhawan and A.K. Singla. Composition and a method of maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition. U.S. Patent Application S. No. 09/935/057, filed on August 21, 2001b.
30. Internatioanl Conference on Harmonization. Draft guidline on validation of analytical procedure for pharmaceuticals; availability. Fed. Reg. 59:9750 (1994).